Free Trial

Allergy Therapeutics (AGY) Competitors

Allergy Therapeutics logo
GBX 8.25 0.00 (0.00%)
As of 07/11/2025 11:49 AM Eastern

AGY vs. AMYT, APH, ANCR, VLG, DNL, EAH, STX, PXS, CHLL, and MXC

Should you be buying Allergy Therapeutics stock or one of its competitors? The main competitors of Allergy Therapeutics include Amryt Pharma (AMYT), Alliance Pharma (APH), Animalcare Group (ANCR), Venture Life Group (VLG), Diurnal Group (DNL), ECO Animal Health Group (EAH), Shield Therapeutics (STX), Provexis (PXS), Chill Brands Group (CHLL), and Argent BioPharma (MXC). These companies are all part of the "drug manufacturers - specialty & generic" industry.

Allergy Therapeutics vs. Its Competitors

Allergy Therapeutics (LON:AGY) and Amryt Pharma (LON:AMYT) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, earnings, analyst recommendations, dividends, profitability, media sentiment, risk and valuation.

In the previous week, Allergy Therapeutics had 3 more articles in the media than Amryt Pharma. MarketBeat recorded 3 mentions for Allergy Therapeutics and 0 mentions for Amryt Pharma. Allergy Therapeutics' average media sentiment score of 0.37 beat Amryt Pharma's score of 0.00 indicating that Allergy Therapeutics is being referred to more favorably in the media.

Company Overall Sentiment
Allergy Therapeutics Neutral
Amryt Pharma Neutral

Amryt Pharma has a net margin of 0.00% compared to Allergy Therapeutics' net margin of -72.86%. Amryt Pharma's return on equity of 0.00% beat Allergy Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Allergy Therapeutics-72.86% -266.59% -34.76%
Amryt Pharma N/A N/A N/A

Amryt Pharma has higher revenue and earnings than Allergy Therapeutics. Allergy Therapeutics is trading at a lower price-to-earnings ratio than Amryt Pharma, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Allergy Therapeutics£72.18M5.62-£52.59M-£1.04-7.95
Amryt Pharma£210.24M0.00N/A-£33.00N/A

Summary

Amryt Pharma beats Allergy Therapeutics on 5 of the 8 factors compared between the two stocks.

Get Allergy Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for AGY and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AGY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AGY vs. The Competition

MetricAllergy TherapeuticsDrug Manufacturers IndustryMedical SectorLON Exchange
Market Cap£405.49M£2.18B£5.61B£3.00B
Dividend Yield8.33%2.92%5.24%5.02%
P/E Ratio-7.954.1527.96150.88
Price / Sales5.62562.62430.89314,545.52
Price / Cash3.6610.3537.4627.97
Price / Book83.6011.478.044.59
Net Income-£52.59M£21.15B£3.18B£5.90B
7 Day Performance3.13%0.32%3.67%11.51%
1 Month Performance25.00%5.94%4.09%7.90%
1 Year Performance47.85%2.25%29.58%32.03%

Allergy Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AGY
Allergy Therapeutics
N/AGBX 8.25
flat
N/A+52.8%£405.49M£72.18M-7.95612News Coverage
AMYT
Amryt Pharma
N/AN/AN/AN/A£457.11M£210.24M-4.33290Gap Down
APH
Alliance Pharma
1.8433 of 5 stars
GBX 64.70
flat
GBX 6,250
+9,560.0%
N/A£350.32M£183.50M-10.4391,000
ANCR
Animalcare Group
N/AGBX 295
+1.4%
N/A+24.5%£202.25M£84.90M5.50220
VLG
Venture Life Group
N/AGBX 59.40
+0.7%
N/A+20.8%£75.69M£51.77M100.80165Positive News
DNL
Diurnal Group
N/AN/AN/AN/A£46.33M£4.68M-3.2133
EAH
ECO Animal Health Group
N/AGBX 61
+1.7%
N/A-54.3%£41.33M£89.44M39.43234
STX
Shield Therapeutics
N/AGBX 2.88
+1.1%
N/A+91.0%£28.42M£20.92M-0.7440,000
PXS
Provexis
N/AGBX 0.76
-1.9%
N/A+29.9%£17.83M£846.98K-28.814Gap Down
CHLL
Chill Brands Group
N/AN/AN/AN/A£10.89M£624.19K-215.007News Coverage
Earnings Report
MXC
Argent BioPharma
N/AN/AN/AN/A£9.65M£1.32M-13.255Gap Up

Related Companies and Tools


This page (LON:AGY) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners